Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hardwick

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2011
Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Craig D Fisher, Mark J Canet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 25, 2011
Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitisRhiannon N Hardwick, Craig D Fisher, Stephanie M Street, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2010
Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Craig D Fisher, Mark J Canet, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2014
Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expressionJohn D Clarke, Rhiannon N Hardwick, April D Lake, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2013
Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liverNathan D Pfeifer, Arlene S Bridges, Brian C Ferslew, et al.
The British Journal of Dermatology|February 1, 1989
Exogenous ochronosis: an epidemiological studyN Hardwick, L W Van Gelder, C A Van der Merwe, et al.
Lab on a Chip|October 11, 2019
Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assaysRhiannon N Hardwick, Catherine J Betts, Jessica Whritenour, et al.
Molecular Pharmaceutics|January 14, 2014
An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdownKyunghee Yang, Nathan D Pfeifer, Rhiannon N Hardwick, et al.
Gene|October 25, 2011
Genetic variation in the mouse model of Niemann Pick C1 affects female, as well as male, adiposity, and hepatic bile transporters but has indeterminate effects on caveolaeDavid A Jelinek, Bita Maghsoodi, Ivan A Borbon, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 23, 2014
Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the ratMichael Kyriakides, Rhiannon N Hardwick, Zhaosheng Jin, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2011
Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Craig D Fisher, Mark J Canet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 25, 2011
Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitisRhiannon N Hardwick, Craig D Fisher, Stephanie M Street, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2010
Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Craig D Fisher, Mark J Canet, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2014
Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expressionJohn D Clarke, Rhiannon N Hardwick, April D Lake, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2013
Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liverNathan D Pfeifer, Arlene S Bridges, Brian C Ferslew, et al.
The British Journal of Dermatology|February 1, 1989
Exogenous ochronosis: an epidemiological studyN Hardwick, L W Van Gelder, C A Van der Merwe, et al.
Lab on a Chip|October 11, 2019
Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assaysRhiannon N Hardwick, Catherine J Betts, Jessica Whritenour, et al.
Molecular Pharmaceutics|January 14, 2014
An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdownKyunghee Yang, Nathan D Pfeifer, Rhiannon N Hardwick, et al.
Gene|October 25, 2011
Genetic variation in the mouse model of Niemann Pick C1 affects female, as well as male, adiposity, and hepatic bile transporters but has indeterminate effects on caveolaeDavid A Jelinek, Bita Maghsoodi, Ivan A Borbon, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 23, 2014
Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the ratMichael Kyriakides, Rhiannon N Hardwick, Zhaosheng Jin, et al.
Pageof 6